0001104659-21-046654.txt : 20210405 0001104659-21-046654.hdr.sgml : 20210405 20210405171430 ACCESSION NUMBER: 0001104659-21-046654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White William Richard CENTRAL INDEX KEY: 0001778739 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 21806509 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm2112039-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-04-01 0 0001744659 Akero Therapeutics, Inc. AKRO 0001778739 White William Richard C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock 2021-04-01 4 M 0 50000 7.01 A 52270 D Common Stock 2021-04-01 4 S 0 48851 28.6281 D 3419 D Common Stock 2021-04-01 4 S 0 1149 29.2908 D 2270 D Stock Option (Right to Buy) 7.01 2021-04-01 4 M 0 50000 0 D 2029-04-04 Common Stock 50000 364029 D Shares sold pursuant to a Rule 10b5-1 trading plan dated October 5, 2020, as amended on November 18, 2020 previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $28.25 to $29.18, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $29.25 to $29.35, inclusive. 25% of this option vested on April 1, 2020, and the remaining 75% of this option shall vest in 36 equal monthly installments thereafter. /s/ Jonathan Young, Attorney-in-fact 2021-04-05